Infringement Analysis in Vancouver.

A patent infringement analysis Vancouver rights-holders can rely on has to be built for the way Canada actually litigates patents — before a national specialist court that alone can strike a patent down, through common-law documentary and oral discovery, and against a US filing that usually runs in parallel. Vancouver is British Columbia’s innovation engine: the birthplace of the global hydrogen and fuel-cell cluster around Ballard Power Systems and Westport Fuel Systems, a deep life-sciences and biotech base, a fast-growing software, gaming and clean-energy scene, and a century of mining and mineral-processing technology. Almost every patent that matters here is also filed in the United States, so the infringement question is cross-border from the start. PerspireIP builds the element-by-element claim charts and dated evidence-of-use that a Federal Court judge, a BC Supreme Court judge and opposing counsel on discovery can test and adopt.

Where a patent infringement analysis Vancouver case is heard

Canada gives a Vancouver patentee two possible forums, and the difference between them is decisive. The Federal Court of Canada hears the overwhelming majority of patent litigation and, critically, holds exclusive jurisdiction to impeach a patent — to declare it invalid with in rem effect that binds the world under section 60 of the Patent Act. The provincial superior court, the British Columbia Supreme Court in Vancouver, has concurrent jurisdiction over infringement only: it can find a defendant liable and award a remedy between the parties, but it cannot strike the patent from the register. In practice that single distinction pushes most serious BC disputes into the Federal Court, whose bench sits nationally and hears patents week in and week out.

The Federal Court is a national court with a registry in Vancouver, so a British Columbia claimant does not have to travel east to sue. Appeals run to the Federal Court of Appeal and, on leave, to the Supreme Court of Canada. Proceedings may be conducted in English or French, Canada’s two official languages, at the party’s election. Choosing the forum is a strategic call the infringement analysis has to inform: the Federal Court for a case where validity is genuinely in play or a register-clearing judgment is wanted, the BC Supreme Court where the fight is purely about infringement and a provincial remedy.

• Federal Court of Canada — national specialist forum with a Vancouver registry; exclusive jurisdiction to invalidate a patent in rem and the usual home for infringement plus validity
• British Columbia Supreme Court — can hear infringement between the parties but cannot invalidate a patent erga omnes
• Appeals — Federal Court of Appeal, then the Supreme Court of Canada on leave
• Language — proceedings in English or French at the party’s choice

Discovery: how Canada proves infringement

The feature that most sharply separates Canadian patent litigation from continental Europe is discovery. Canada is a common-law jurisdiction, so both documentary discovery and oral examination for discovery are available: each side must produce the relevant documents in its power, possession or control, and a representative of the opposing party is examined under oath before trial. For a rights-holder that means the batch records, source code, design files, test data and internal correspondence that prove infringement can be compelled — there is no need for the court-ordered raids a French or Belgian claimant must rely on because those systems lack discovery.

That changes how the analysis must be written. A useful patent infringement analysis Vancouver counsel can run frames the discovery plan from the outset: it identifies, element by element, exactly which documents and admissions would confirm or defeat each claim limitation, so requests to admit and examination questions are targeted rather than fishing. The Federal Court’s active case-management judges expect that discipline, and a chart that already anticipates the discovery record is far more persuasive than one built on public information alone.

• Documentary discovery — each party produces relevant documents in its power, possession or control, including technical and manufacturing records
• Oral examination for discovery — a representative of the opposing party is examined under oath before trial, yielding admissions that map directly onto claim limitations
• No self-help seizure needed — unlike civil-law Europe, Canada compels evidence through discovery rather than a descriptive seizure
• Analysis drives the plan — the claim chart identifies the documents and admissions that would prove each element, focusing discovery from day one

Validity and the end of the promise doctrine

Validity is almost always contested. A defendant sued in the Federal Court will routinely counterclaim for impeachment, and any interested person can bring a stand-alone impeachment action, so the infringement read has to be built alongside a candid validity assessment. A Canadian patent is presumptively valid, and the party attacking it carries the burden of proving invalidity on the balance of probabilities — on grounds of anticipation, obviousness, insufficiency, overbreadth or lack of utility.

One recent shift matters more than any other for utility. In AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36, the Supreme Court of Canada abolished the so-called “promise doctrine”, under which a patent could be invalidated for failing to deliver every use its specification promised — a rule that had felled a string of pharmaceutical patents. The utility bar is now a “mere scintilla”: a single use related to the subject-matter of the invention will do. For a Vancouver life-sciences or cleantech patentee that is a materially stronger position than a decade ago, and the analysis should reflect the post-AstraZeneca standard rather than the abandoned promise line of cases.

• Presumption of validity — the challenger bears the burden of proving invalidity on the balance of probabilities
• Impeachment counterclaim — validity and infringement are typically litigated together in the Federal Court
• Promise doctrine abolished — AstraZeneca v. Apotex (2017 SCC 36) ended invalidation for unmet promises; utility now needs only a scintilla
• Common grounds — anticipation, obviousness, insufficiency and overbreadth remain the live attacks a chart must anticipate

Vancouver’s docket: fuel cells, cleantech, biotech, mining and software

Vancouver’s patent docket is written by its industries, and the region punches far above its size. It is the historic home of the global hydrogen and fuel-cell cluster — Ballard Power Systems, incorporated in British Columbia and a world leader in proton-exchange-membrane fuel cells, and Westport Fuel Systems, headquartered in the city and building hydrogen and gaseous-fuel engine technology. These disputes turn on membrane-electrode-assembly, catalyst, stack-architecture and fuel-injection claims, proven from teardown, materials analysis and performance data. Around them sits a broader clean-technology and energy-storage sector that BC has cultivated for decades.

The second pillar is life sciences and biotech, clustered around the University of British Columbia and the city’s hospital-research institutes, where formulation, biologic, diagnostic and process claims raise the hardest utility and sufficiency questions — the very ground reshaped by AstraZeneca. Vancouver also carries a fast-growing software, video-game and AI economy and, reaching back a century, a deep mining and mineral-processing technology base tied to BC’s resource sector. Each writes its own claim-mapping and evidence demands, and each typically pairs a Canadian patent with a US one.

• Fuel cells & hydrogen — membrane-electrode-assembly, catalyst, stack and fuel-system claims from the Ballard/Westport ecosystem, mapped from teardown and performance data
• Cleantech & energy storage — power-electronics, electrolyser and battery claims proven from deployed hardware and test records
• Life sciences & biotech — formulation, biologic, diagnostic and process claims where utility and sufficiency are decisive post-AstraZeneca
• Software, gaming & mining tech — source-code, systems and mineral-processing claims proven through documentary discovery and expert reconstruction

Building claim charts and evidence-of-use for the Federal Court

The Federal Court’s specialist judges and its active case management expect a disciplined evidentiary file — a chart that can be verified on the discovery record and defended by an expert, not merely argued. We start from claim construction under the purposive approach Canadian courts apply, working through the claims, the specification and the prosecution history, then map each limitation against the real accused product or process, literally and, where appropriate, under Canadian equivalents analysis.

• Element-by-element claim charts tying every limitation to a documented, dated piece of evidence and to the specific discovery request or admission that would confirm it
• Fuel-cell and cleantech evidence-of-use from teardown, materials and catalyst analysis, power-electronics inspection and performance telemetry
• Life-sciences evidence-of-use from formulation, process and analytical data, with a utility and sufficiency read aligned to the post-AstraZeneca standard
• Software and mining-tech evidence-of-use from source code, systems behaviour and operational records obtained on discovery
• Non-infringement and design-around positions for an accused party, anchored to the specification and the file wrapper
• A coordinated invalidity file, because an impeachment counterclaim almost always runs alongside the infringement action in the Federal Court

The deliverable is scoped to the forum. A Federal Court action with its discovery track, a focused BC Supreme Court infringement claim, or a cross-border matter coordinated with parallel US litigation each demands a slightly different package. What never changes is the core: a claim chart a Canadian judge and an independent expert can adopt, built on evidence rather than conclusions.

How PerspireIP scopes a Vancouver infringement-analysis engagement

Every engagement follows the same path. We fix the correct purposive claim construction, map each element against the accused product or process, and assemble evidence-of-use in the form the technology demands — teardown and materials data for fuel cells and cleantech, formulation and process data for life sciences, source code and systems evidence for software, mineral-processing records for mining tech. Then we build the file the Canadian process actually uses: material a Federal Court discovery plan can secure and an expert can verify.

• Purposive claim construction and element-by-element charting against a Canadian patent, coordinated with any parallel US or foreign counterpart
• Evidence-of-use assembly dated and documented for the Federal Court or the BC Supreme Court, with a discovery plan built into the chart
• Infringement and non-infringement positions built for either side, coordinated with any impeachment counterclaim and a post-AstraZeneca validity read
• Deliverables scoped to the track — a Federal Court statement of claim, a BC Supreme Court infringement claim, or cross-border support alongside US counsel

We work alongside your Canadian and US counsel as a specialist analysis partner, deliver to Federal Court deadlines, and keep every engagement confidential. Whether you are a fuel-cell or cleantech company, a biotech or life-sciences firm, a software or mining-technology business enforcing a portfolio, an accused party clearing a path to market, or litigation counsel preparing a claim or a defence, we scale to fit — a single claim chart, a multi-patent matter, or ongoing portfolio support. Send us the patent number and the accused product, and we will scope the work within one business day.

IP Landscape & Resources in Vancouver

Key intellectual-property authorities and venues relevant to Vancouver:

• Canadian Intellectual Property Office (CIPO) — the special operating agency of Innovation, Science and Economic Development Canada that grants Canadian patents and maintains the patent register
• Federal Court of Canada — the national court that hears most Canadian patent litigation and holds exclusive jurisdiction to invalidate (impeach) a patent with in rem effect, with a registry in Vancouver
• Federal Court of Appeal — the court that hears appeals from Federal Court patent judgments, below the Supreme Court of Canada
• Supreme Court of Canada — Canada's highest court, whose 2017 AstraZeneca v. Apotex decision abolished the promise doctrine and reset the utility standard for patents

Request a Patent Infringement Analysis in Vancouver

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions